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To relieve endoplasmic reticulum (ER) stress, IRE1 splices XBP1 messenger RNA (mRNA) or engages regulated IRE1-
dependent decay (RIDD) of other mRNAs. Upon XBP1 deficiency, IRE1 switches to perform RIDD. We examined IRE1 in 
XBP1-deficient B cells and discovered that IRE1 undergoes phosphorylation at S729. We generated an anti–phospho-S729 
antibody to investigate such phosphorylation. Compared with pharmacological ER stress inducers or Toll-like receptor 
ligands, the bacterial subtilase cytotoxin has an unusual capability in causing rapid and strong phosphorylation at S729 
and triggering B cells to express spliced XBP1. To assess the function of S729 in IRE1, we generated S729A knock-in mice 
and found S729 is critically important for lipopolysaccharide-stimulated plasmablasts to respond to additional ER stress 
and for antibody production in response to immunization. We further crossed mice carrying an S729A mutation or ΔIRE1 
(missing the kinase domain) with B cell–specific XBP1-deficient mice to trigger RIDD and discovered a critical role for 
S729 in regulating RIDD in B cells.
Phosphorylation of IRE1 at S729 regulates RIDD in B 
cells and antibody production after immunization
Chih‑Hang Anthony Tang1, Shiun Chang1, Adrienne W. Paton2, James C. Paton2, Dmitry I. Gabrilovich1, Hidde L. Ploegh3, Juan R. Del Valle4, 
and Chih‑Chi Andrew Hu1
Introduction
The ER is responsible for the folding and assembly of ∼30% 
of proteins encoded by our genome. Many secretory and 
membrane-bound proteins are important cytokines and surface 
receptors. The ER harbors complex, yet elegant, mechanisms to 
control protein folding and assembly and to dispose of terminally 
misfolded proteins. To respond to ER stress, the ER is equipped 
with transmembrane sensors IRE1, PERK, and ATF6, represent-
ing the three major arms of the unfolded protein response (UPR), 
which help cells relieve the stress and restore homeostasis (Ron 
and Walter, 2007; Walter and Ron, 2011). In the case of persistent 
and irreversible stress, the ER can also dictate cell death. Aber-
rant regulation of the UPR is implicated in many diseases (Lin et 
al., 2008; Hetz et al., 2013; Hetz and Mollereau, 2014; Bettigole 
and Glimcher, 2015; Chevet et al., 2015; Grootjans et al., 2016).
The ER stress sensor, IRE1, is critical for B cells. Normal B cell 
development in the bone marrow requires IRE1 (Zhang et al., 
2005). Upon encountering its cognate antigen, a B cell differ-
entiates into a plasma cell, which can produce large quantities 
of high-affinity antibodies against the antigen. IRE1 is indis-
pensable in this process because its cytoplasmic kinase/RNase 
domain, upon stimulation for differentiation, can assemble into 
a functional RNase that specifically splices 26 nucleotides from 
mammalian XBP1 mRNA (Shen et al., 2001; Yoshida et al., 2001; 
Calfon et al., 2002; Korennykh et al., 2009). The spliced XBP1 
(XBP1s) mRNA encodes a functional 54-kD transcription factor, 
XBP1s, as a result of a frame shift in translation (Calfon et al., 
2002). XBP1s up-regulates the synthesis of lipids and chaperones, 
contributing to the ER expansion and increased Ig production in 
plasma cells (Lee et al., 2003; Sriburi et al., 2004; McGehee et 
al., 2009). In response to Toll-like receptor (TLR) ligands such as 
lipopolysaccharide (LPS; a TLR4 ligand) or cytosine-phosphate- 
guanine (CpG) DNA (a TLR9 ligand), B cells activate the IRE1–XBP1 
pathway and produce large quantities of secretory IgM (sIgM; 
Reimold et al., 2001; Iwakoshi et al., 2003; Hu et al., 2009a). Data 
showing vastly decreased sIgM in stimulated IRE1- (Zhang et al., 
2005) and XBP1-deficient B cells (Reimold et al., 2001; Iwakoshi 
et al., 2003; Hu et al., 2009a) support the role of the IRE1–XBP1 
pathway in antibody production.
Other than splicing XBP1 mRNA, the RNase of IRE1 can rapidly 
cleave a subset of mRNAs and so halts the production of proteins 
that challenge the ER. This mechanism is known as regulated 
IRE1-dependent decay (RIDD; Hollien and Weissman, 2006). We 
showed previously that genetic deletion of the XBP1 gene leads to 
elevated protein levels of IRE1 in B cells (Hu et al., 2009a). Recently, 
the mRNA of secretory Ig μ (μS) heavy chain was shown to be an 
RIDD substrate, and increased levels of IRE1 in XBP1-deficient B 
cells contribute to decreased levels of sIgM by cleaving μS mRNA 
(Benhamron et al., 2014). Ablation of the RNase activity of IRE1 in 
XBP1-deficent B cells inhibits the RIDD of μS mRNA (Benhamron 
et al., 2014). RIDD is clearly important in B cells because it protects 
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XBP1-deficient B cells from accumulating unfolded proteins in the 
ER by degrading μS mRNA, which encodes one of the most abun-
dant ER proteins in B cells. Enhanced RIDD in response to XBP1 
deficiency is also critical in regulating proinsulin processing and 
insulin secretion in pancreatic β-cells (Lee et al., 2011), protecting 
hepatocytes from acetaminophen-induced hepatotoxicity (Hur 
et al., 2012) and suppressing lipogenesis and lipoprotein metab-
olism (So et al., 2012). In response to prolonged ER stress, RIDD 
is responsible for the decay of specific microRNAs that repress 
translation of the caspase-2 mRNA, causing drastically elevated 
levels of caspase-2 (Upton et al., 2012).
We identified that IRE1 is phosphorylated at S729 in XBP1-de-
ficient mouse B cells. By generating and using a specific anti–
phospho-S729 antibody, we confirmed that S729 is indeed 
phosphorylated in XBP1-deficient B cells and discovered that 
phosphorylation of S729 only occurs under certain ER stress 
conditions. Next, we generated a knock-in mouse model, S729A, 
and showed that, although B cells from mice carrying the S729A 
mutation can respond to LPS-stimulated B cell differentiation by 
producing XBP1s, they fail to respond to additional pharmaco-
logic or bacterial toxin insults. To investigate the role of S729 and 
the kinase domain of IRE1 in regulating RIDD, we crossed S729A 
and IRE1f/f mice with B cell-specific XBP1 knockout (KO; XBP1KO; 
CD19Cre/XBP1f/f) mice to trigger RIDD. Our results showed that 
S729 phosphorylation of IRE1 is critical for enhancing the splic-
ing of XBP1 mRNA and engaging RIDD in cultured B cells and 
plasma cells in immunized mice.
Results
IRE1 responded to XBP1 deficiency by undergoing 
phosphorylation at S729
To investigate the role of IRE1 in XBP1-deficient B cells, we stim-
ulated naive B cells purified from the spleens of XBP1WT and 
XBP1KO mice with LPS and CpG-1826. Both LPS- and CpG-1826–
stimulated B cells produced large quantities of Ig κ light chains 
(Fig.  1 A). LPS-stimulated B cells produced significantly more 
sIgM than did CpG-1826–stimulated B cells. CpG-1826–stimulated 
B cells produced more membrane-bound IgM. Although the 
lack of XBP1 in B cells did not affect the production of mem-
brane-bound IgM or κ light chains, it led to significantly sup-
pressed expression of sIgM, which was attributed to increased 
expression levels of IRE1 and RIDD (Fig.  1  A; Benhamron et 
al., 2014). The expression level of IRE1 was up-regulated after 
stimulation with LPS or CpG-1826 (Fig. 1 A; Hu et al., 2009a). 
To compare the synthesis of IRE1 in LPS-stimulated XBP1- 
proficient and -deficient B cells, we pulse-labeled the cells using 
[35S]methionine and [35S]cysteine for 15 min, performed a 2-h 
chase experiment in the presence of cold methionine and cys-
teine, and immunoprecipitated IRE1 using an anti–mouse IRE1 
antibody generated in house. In contrast with XBP1-proficient B 
cells, XBP1-deficient B cells produced more IRE1, which shifted 
to a higher molecular weight after a 30-min chase and thereafter 
(Fig. 1 B). We demonstrated that the molecular weight shift of 
IRE1 was a result of phosphorylation by performing a pulse-chase 
experiment coupled with digestion of the immunoprecipitated 
IRE1 using λ protein phosphatase (λPPase; Fig. 1 C).
To identify the phosphorylated residues of IRE1, we immu-
noprecipitated IRE1 from LPS-stimulated, XBP1-deficient and 
-proficient B cells using the anti–IRE1 antibody and analyzed 
the immunoprecipitates by SDS-PAGE. IRE1 and other proteins 
were visualized by staining with Coomassie brilliant blue (G-250; 
Fig.  1  D). The band corresponding to the molecular weight of 
IRE1 was excised from the gel, in-gel digested, and subjected 
to peptide sequencing by liquid chromatography–tandem mass 
spectrometry (LC-MS/MS). Single-peptide matches for protein 
identifications and all phosphorylated peptides were further 
verified by manual inspection of the tandem mass spectra (and 
relatively quantified using extracted ion chromatograms [XICs]). 
Most peptides detected in our LC-MS/MS analysis belonged to 
IRE1. By using various enzymes (trypsin, chymotrypsin, or both 
combined) for proteolytic digestion in different experiments, we 
recovered peptides that covered >95% of the mouse IRE1 cyto-
plasmic domain sequence for a relatively thorough phosphoryla-
tion analysis. By XIC analysis, we detected clear phosphorylation 
of S729 in IRE1 in response to XBP1 deficiency (Fig. 1, E and F), 
with no evidence suggesting that S724 or S726 was phosphory-
lated in multiple LC-MS/MS analyses, and by using a commercial 
antibody against phospho-S724.
To investigate the role of S729, we immunized rabbits with a 
synthetic IRE1 peptide containing phosphorylated S729 residue 
(Fig.  1  G) and affinity-purified anti–phospho-S729 antibodies 
using exactly the same peptide. The antibodies were further 
purified using a synthetic backbone peptide (Fig. 1 G) to deplete 
those that recognize nonphosphorylated IRE1. To characterize our 
anti–phospho-S729 antibody, we treated naive XBP1-proficient 
and -deficient B cells with LPS for a course of 72 h, immunopre-
cipitated IRE1 using an anti–mouse IRE1 antibody, and showed 
that this antibody recognizes the 130-kD phospho-IRE1 protein 
produced by 48-h and 72-h LPS-stimulated XBP1-deficient B cells 
(Fig. 1 H). To examine whether S729 phosphorylation occurred in 
LPS-stimulated XBP1-proficient B cells, we immunoprecipitated 
IRE1 from 10 times more XBP1-proficient B cell lysates so that the 
backbone IRE1 became comparable with that in XBP1-deficient 
B cell lysates. We did not detect S729 phosphorylation of IRE1 in 
XBP1-proficient cell lysates by immunoblots (Fig. 1 I). We also 
treated immunoprecipitated IRE1 with calf intestinal phosphatase 
(CIP) or λPPase and showed that IRE1 did not undergo phosphory-
lation in LPS-stimulated XBP1-proficient B cells (Fig. 1 J), consis-
tent with pulse-chase data (Fig. 1 B). We have shown that subti-
lase cytotoxin (SubAB) produced by Shiga-toxigenic Escherichia 
coli specifically cleaved BiP (Paton et al., 2006) and led to phos-
phorylation of IRE1 (Hu et al., 2009b); however, the phosphor-
ylated residue was not known. We treated 48-h LPS-stimulated 
XBP1-proficient and -deficient B cells with SubAB for 24 h and 
showed that our anti–phospho-S729 antibody recognized phos-
phorylated IRE1 in SubAB-treated B cells (Fig. 1 H). To confirm 
the phosphospecificity of our anti–phospho-S729 antibody, we 
treated 5TGM1 mouse multiple myeloma cells with SubAB immu-
noprecipitated IRE1 using an anti–IRE1 antibody and incubated 
immunoprecipitated IRE1 with λPPase or CIP before immunoblot-
ting using the anti–phospho-S729 antibody. This antibody recog-
nized phosphorylated IRE1 in SubAB-treated 5TGM1 cells and did 
not react with that preincubated with λPPase or CIP (Fig. 1 K).
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SubAB was potent in inducing S729 phosphorylation of IRE1, 
which could be rapidly suppressed by KIRA6
To investigate the role of S729 phosphorylation, we treated 5TGM1 
cells with DTT, brefeldin A (BFA), B-I09 (an IRE1 RNase inhibitor; 
Tang et al., 2014), MG132, SubAB, thapsigargin (Tg), or tunicamycin 
(Tu; Fig.  2  A). We performed time-course experiments using 
5 mM DTT, based on our result showing that 5 mM DTT induced 
the highest phosphorylation at S729 of IRE1 in dose-dependent 
experiments, and observed that S729 phosphorylation occurred 
at the 45-min time point, whereas significantly increased XBP1s 
Figure 1. IRE1 is phosphorylated at S729 in 
XBP1-deficient B cells. (A) Naive XBP1WT and 
XBP1KO B cells were stimulated with LPS (20 µg/
ml) or CpG-1826 (0.5 µM) for 3 d. Lysates were 
immunoblotted for indicated proteins. (B) 3-d 
LPS-stimulated XBP1WT and XBP1KO B cells were 
starved in cysteine- and methionine-free media 
for 1 h, radiolabeled for 15 min, and chased for 
a course of 2  h. Lysates were immunoprecipi-
tated (IP) for IRE1, which was then analyzed by 
SDS-PAGE and autoradiography. (C) 3-d LPS- 
stimulated XBP1KO B cells were starved for 50 
min, radiolabeled for 10 min, and chased. Lysates 
were immunoprecipitated for IRE1, which was 
boiled in 1% SDS containing 5 mM DTT, further 
diluted to contain 0.05% SDS and 0.5% NP-40, 
and reimmunoprecipitated using the same anti–
IRE1 antibody. Bead-bound IRE1 was further 
treated with λPPase for 3 h and analyzed by SDS-
PAGE and autoradiography. (D) LPS-stimulated 
XBP1WT and XBP1KO B cell lysates were immuno-
precipitated for IRE1, analyzed by SDS-PAGE, and 
stained with Coomassie brilliant blue G-250. The 
closed triangle marks IRE1, confirmed by LC-MS/
MS sequencing. HC, IgG heavy chains; LC, IgG 
light chains; M, molecular weight. (E) The unmod-
ified peptide, aa 726–743, was detected as a tri-
ply protonated molecule at m/z 648.3312 (−0.71 
ppm error) and assigned with a MAS COT score 
of 50. (F) The corresponding phosphopeptide 
was detected at 674.9878 (−1.3 ppm error) with 
a MAS COT score of 35. The ions in the tandem 
spectra are labeled and marked in the sequence. 
S indicates the phosphorylation. (G) Amino acid 
sequences of the phosphopeptide and backbone 
peptide of IRE1 for generation and purification of 
the anti–phospho-S729 antibody. (H) XBP1WT and 
XBP1KO B cells were stimulated with LPS for 72 h. 
Some LPS-stimulated B cells were exposed to 
SubAB in the last 24 h of the time course. Lysates 
were immunoblotted for the indicated proteins 
or immunoprecipitated with an anti–mouse IRE1 
antibody before immunoblotting with the anti–
phospho-S729 antibody. (I) XBP1WT and XBP1KO B 
cells were stimulated with LPS for 72 h. 10 times 
more XBP1WT B cell lysates were used for immu-
noprecipitation for IRE1, which was then immu-
noblotted with the anti–phospho-S729 antibody. 
IRE1 and p97 immunoblots are input controls. (J) 
3-d LPS-stimulated XBP1WT and XBP1KO B cells 
were lysed and immunoprecipitated for IRE1. 
Bead-bound IRE1 was treated with CIP or λPPase 
for 3 h and immunoblotted for IRE1. (K) 5TGM1 
myeloma cells were exposed to SubAB for 16 h. 
Lysates were immunoprecipitated for IRE1. Bead-
bound IRE1 was treated with λPPase or CIP for 3 h 
and immunoblotted for the indicated proteins. 
The p97 immunoblot is an input control. Data 
in this figure are representative of at least three 
independent experiments. WB, Western blot.
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occurred at the 3-h time point (Fig. 2, B and C). We then performed 
time-course and dose-dependent experiments for SubAB (Fig. 2, D 
and E), Tg (Fig. S1, A and B), Tu (Fig. S1, C and D), BFA (Fig. S1, E and 
F), and MG132 (Fig. S1, G and H) and compared results with those 
treated with 5 mM DTT for 3 h in all experiments. Compared with 
DTT, 1.5 nM SubAB cleaved BiP and induced increased synthesis 
and phosphorylation of IRE1 accompanied by the expression of 
XBP1s in the course of 24-h treatment (Fig. 2 D). Phosphorylation of 
S729 was also detected in experiments using lower concentrations 
of SubAB (Fig. 2 E). Tg induced S729 phosphorylation to a much 
lesser degree than DTT in both time-course and dose-dependent 
experiments (Fig. S1, A and B). In repeated time-course and 
dose-dependent experiments, we did not detect S729 phosphory-
lation in cells treated with Tu (Fig. S1, C and D), BFA (Fig. S1, E and 
F), or MG132 (Fig. S1, G and H). 5TGM1 cells treated with MG132 
expressed reduced levels of IRE1 after 4 h (Fig. S1 G) because of 
rapid apoptosis but not lysosomal degradation (Fig. S1 I); however, 
those treated with BFA or Tu at least maintained, if not increased, 
the expression levels of IRE1 (Fig. S1, C–F). Untreated 5TGM1 cells 
as well as those treated with Tu, BFA, or MG132 all expressed XBP1s 
despite the lack of S729 phosphorylation (Fig. S1, C–H), suggesting 
that S729 phosphorylation of IRE1 was not required for initial acti-
vation of XBP1s. We immunoprecipitated IRE1 from untreated as 
well as Tu- and BFA-treated 5TGM1 cells, dephosphorylated IRE1 
using CIP, and showed that IRE1 in untreated or Tu- or BFA-treated 
5TGM1 cells was phosphorylated at other sites (Fig. S1, J and K).
KIRA6, an IRE1 kinase inhibitor, was shown to inhibit IRE1 
from splicing XBP1 mRNA and cleaving insulin mRNA (Ghosh 
et al., 2014). We tested whether KIRA6 could affect S729 phos-
phorylation of IRE1 by treating 5TGM1 cells with SubAB in the 
presence of increasing concentrations of KIRA6 for 12 h (Fig. S2 
A). KIRA6 suppressed SubAB-induced S729 phosphorylation of 
Figure 2. DTT and SubAB induce IRE1 to 
undergo strong and rapid phosphorylation at 
S729. (A) 5TGM1 cells were treated with 5 mM 
DTT for 3 h or with 3.5 µM BFA, 20 µM B-I09, 
50 µM MG132, 1 nM SubAB, 2.5 µM Tg, or 5 µg/ml 
Tu for 12 h. Lysates were immunoblotted for the 
indicated proteins. (B) 5TGM1 cells were treated 
with 5 mM DTT for the indicated times and immu-
noblotted. (C) 5TGM1 cells were treated with 
DTT at the indicated concentrations for 3 h and 
immunoblotted. (D) 5TGM1 cells were treated 
with 5 mM DTT for 3 h or with 1.5 nM SubAB for 
24 h and immunoblotted. (E) 5TGM1 cells were 
treated with 5 mM DTT for 3 h or with SubAB for 
12 h using increasing concentrations and immu-
noblotted. (F) 5TGM1 cells were exposed to 1 nM 
SubAB for 12 h and were subsequently treated 
with KIRA6, staurosporine, imatinib, or sunitinib 
at 5 µM for an additional 2 h and then immuno-
blotted. Data in this figure are representative of 
three independent experiments.
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IRE1 in a dose-dependent manner, with little impact on the lev-
els of XBP1s. In addition, we treated 5TGM1 cells with SubAB for 
12 h and then exposed such cells to 5 µM KIRA6 for a course of 
8 h (Fig. S2 B). KIRA6 rapidly suppressed S729 phosphorylation 
without affecting the levels of XBP1s. KIRA6 also did not suppress 
phosphorylation of IRE1 at other sites (Fig. S2 C). Compared with 
staurosporine (a broad-spectrum kinase inhibitor that binds to 
IRE1; Concha et al., 2015), imatinib (a tyrosine kinase inhibitor 
that activates IRE1 in cardiomyocytes; Kerkelä et al., 2006), or 
sunitinib (a receptor tyrosine kinase inhibitor that binds to IRE1; 
Korennykh et al., 2009; Ali et al., 2011), KIRA6 was effective in 
suppressing S729 phosphorylation of IRE1 (Figs. 2 F and S2 D).
SubAB but not other AB5 toxins induced S729 
phosphorylation of IRE1
Cytotoxicity of SubAB is a result of BiP cleavage at a dileucine 
motif (Leu417 and Leu418 in mouse BiP); overexpression of BiP 
in which the SubAB cleavage site is eliminated can protect cells 
from SubAB-induced cytotoxicity (Paton et al., 2006). To demon-
strate that SubAB induced S729 phosphorylation through cleav-
ing BiP, we treated 5TGM1 cells with a mutant SubAA272B carrying 
a single serine-to-alanine substitution at the critical Ser272 in 
the catalytic triad (Asp-His-Ser) of its A subunit and showed that 
only native SubAB cleaved BiP and caused S729 phosphorylation 
of IRE1 (Fig. 3 A). Other than SubAB, there are three types of AB5 
toxins: Shiga toxins 1 and 2 from Shigella dysenteriae and E. coli, 
cholera toxin from Vibrio cholera, and pertussis toxin from Bor-
detella pertussis. Similar to SubAB, all three AB5 toxins enter the 
ER through retrograde transport. Although SubAB cleaves BiP in 
the ER, the other AB5 toxins need to be retrotranslocated from 
the ER into the cytoplasm to exert their toxic effects. We treated 
5TGM1 cells with Shiga toxins 1 and 2 (Figs. 3 B and S2 E), chol-
era toxin (Figs. 3 C and S2 F), or pertussis toxin (Figs. 3 D and S2 
G) and investigated the capabilities of these toxins in inducing 
S729 phosphorylation of IRE1. Even when we treated 5TGM1 cells 
with 10 times more concentrated Shiga toxins, cholera toxin or 
pertussis toxin than 1 nM SubAB, we did not detect S729 phos-
phorylation of IRE1 (Fig. S2, E–G). However, we observed slightly 
increased expression of XBP1s in Shiga toxin–, cholera toxin–, 
and pertussis toxin–treated cells (Fig. 3, B–D).
Generation of the S729A knock-in mouse model
To investigate the physiological role of the S729 residue of IRE1, 
we generated a novel knock-in mouse model, S729A (Fig. S3 A). 
We confirmed the long- and short-arm integration of the target-
ing vector by Southern blots (Fig. S3 A) and the presence of the 
desired mutation in the IRE1 gene by DNA sequencing. Purified 
B cells from WT and S729A mice were cultured in the presence 
of LPS for 3 d, radiolabeled for 4 h, and chased for a course of 8 h 
in the absence or presence of SubAB, and the immunoprecipita-
tion results confirmed that LPS could not trigger IRE1 to undergo 
phosphorylation at S729 in WT B cells, but SubAB could (Fig. 4 A).
The percentages of B and T cells changed slightly in 
S729A knock-in mice
To examine B cell development in the bone marrow of S729A 
mice, we analyzed gated B220+ B cell progenitors for CD43+/
CD19low pro–B cells and CD43+/CD19high pre–B cells (Fig. S3 B, 
middle) and detected little change in the percentages of B cell 
progenitors, pro–, or pre–B cells when comparing unimmunized 
S729A with WT mice (Fig. S3, B–E). We also gated the CD43−/
CD19+ population and analyzed them for IgM+/IgD− immature B 
cells and IgM+/IgD+ mature B cells in the bone marrow (Fig. S3 
B, right), and we found that S729A mice exhibit similar percent-
ages of immature and mature B cells when compared with WT 
mice (Fig. S3, F and G). WT and S729A mice were also immunized 
with hen egg lysozyme (HEL), emulsified in complete Freund’s 
adjuvant (CFA), and boosted three times with HEL plus incom-
plete Freund’s adjuvant (IFA). We observed increased numbers 
of pro– and mature B cells in the bone marrow of S729A mice 
(Fig. S3, D and G).
In the spleens of unimmunized and HEL-immunized mice, 
we analyzed the gated CD19+ B cell population and detected no 
difference of this population between WT and S729A mice (Fig. 
S4, A and B). We next gated CD3+ populations to analyze for CD4+ 
and CD8+ T cells. Normal CD4/CD8 T cell ratio and T cell percent-
ages were found in unimmunized WT and S729A mice (Fig. S4, 
A, C, and D); however, increased percentages of CD4+ and CD8+ T 
cells were observed in immunized S729A mice (Fig. S4, C and D). 
We also analyzed the gated CD19+/B220+/GL7−/AA4.1− B cell pop-
ulation for CD1d+/CD23− marginal zone B cells and CD1d−/CD23+ 
follicular B cells in spleens and found no difference between 
unimmunized and immunized WT and S729A mice (Fig. S4, E–G).
In peripheral lymph nodes of unimmunized and HEL-immu-
nized mice, we analyzed the gated CD19+ B cell population and 
found decreased percentages of this population in immunized 
S729A mice (Fig. S4, H and I). We also analyzed the gated CD3+ 
populations for CD4+ and CD8+ T cells and detected increased CD4 
and CD8 T cell percentages in the lymph nodes of immunized 
S729A mice (Fig. S4, H, J, and K).
Immunized S729A mice generated less CD138+ plasma cells, 
which expressed lower levels of XBP1s
To compare the expression levels of XBP1s in plasma cells from 
immunized WT and S729A mice, we characterized a recently 
developed anti-XBP1s mouse monoclonal antibody. This antibody 
recognized human XBP1s expressed by H929 myeloma cells stim-
ulated with DTT and mouse XBP1s produced by A20 B cell lym-
phoma upon SubAB stimulation (Fig. 4, B and C). As a negative 
control for this antibody, B-I09 abolished SubAB-induced expres-
sion of XBP1s in A20 cells (Fig. 4 C). We stained bone marrow cells 
from HEL-immunized WT and S729A mice for CD138, B220, and 
XBP1s and found that CD138+ plasma cells indeed produced higher 
levels of XBP1s than B220+ B cell progenitors (Fig. 4 D). When com-
paring immunized WT and S729A mice, we found decreased per-
centages of CD138+ plasma cells in the bone marrow of S729A mice 
(Fig. 4, D and E) and significantly lower mean fluorescence inten-
sity (MFI) of XBP1s expressed by CD138+ plasma cells in immu-
nized S729A mice (Fig.  4  F). We also found decreased percent-
ages of CD138+ plasma cells in spleens of immunized S729A mice 
(Fig. 4 G), and these plasma cells similarly expressed lower levels 
of XBP1s (Fig. 4 H). Despite the reduced percentages of plasma cells 
in HEL-immunized S729A mice, serum levels of anti–HEL IgG or 
IgG1 remained unabated (Fig. 4, I and J).
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S729A B cells responded to LPS by producing XBP1s but could 
not respond to additional ER insults by up-regulating the 
levels of XBP1s
To further analyze B cell differentiation, we purified naive B 
cells from S729A mice, stimulated them with LPS, and found 
that S729A B cells can express XBP1s, albeit at decreased levels 
(Fig.  5  A). By analyzing LPS- or CpG-1826–stimulated B cells 
stained with the anti-XBP1s antibody, we realized for the first 
time that not all naive B cells can respond to LPS or CpG-1826 
by producing high levels of XBP1s (Fig.  5  B). Compared with 
CpG-1826, LPS induced significantly more B cells to produce 
XBP1s during 3 d of stimulation (Fig. 5 B), consistent with our 
immunoblot data (Fig. 1 A). Next, we stimulated B cells purified 
from S729A mice with LPS for 24 h and monitored the percent-
ages of cells that expressed XBP1s as well as the MFI of XBP1s 
by flow cytofluorometry for an additional 24 h. Compared with 
WT B cells, S729A B cells expressed slightly lower levels of XBP1s 
(Fig. 5, C and D), consistent with our immunoblot data (Fig. 5 A).
To explore how S729A B cells responded to additional ER 
insults, we exposed 2-d LPS-stimulated WT and S729A B cells to 
DTT for 3 h or to Tg or SubAB for 3, 6, 12, and 24 h, and moni-
tored the percentages of XBP1s-expressing B cells and the MFI of 
XBP1s by flow cytofluorometry (Fig. 6, A–C; and Fig. S5, A and B). 
As a negative control, LPS-stimulated B cells were treated with 
B-I09 to shut down the expression of XBP1s (Fig. 6 A). Compared 
with DTT or Tg (Fig. 6, A and B; and Fig. S5 A), SubAB triggered 
most of the LPS-stimulated WT B cells to further express XBP1s, 
resulting in much higher MFI (Figs. 6 C and S5 B). However, all 
these ER stress inducers failed to trigger LPS-stimulated S729A 
B cells to further express XBP1s (Fig. 6, A–C; and Fig. S5, A and 
B), and we confirmed such results by immunoblots (Fig. 6 D). In 
addition, IRE1 immunoprecipitated from SubAB- and DTT- but 
Figure 3. SubAB, but not other AB5 toxins, cleaves BiP and 
induces S729 phosphorylation of IRE1. (A) 5TGM1 cells were 
treated with mutant or native SubAB for 24  h using increas-
ing concentrations and immunoblotted. (B) 5TGM1 cells were 
treated with 1 nM SubAB, 1 nM Shiga toxin 1, or 1 nM Shiga toxin 
2 for 24 h and immunoblotted. Phospho–NF-κB p65 served as a 
control for the activity of the Shiga toxins. (C) 5TGM1 cells were 
treated with 1 nM SubAB for 24 h or with 1 nM cholera toxin for 
24 h and immunoblotted. Phospho-ERK1/2 and phospho–NF-κB 
p105 served as controls for the activity of the cholera toxin. 
(D) 5TGM1 cells were treated with 1 nM SubAB or 1 nM pertussis 
toxin for 24 h and immunoblotted. Phospho–NF-κB p65 served 
as a control for pertussis toxin activity. Data in this figure are 
representative of three independent experiments.
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not Tg-treated S729A B cells could be further dephosphorylated 
with CIP (Fig. 6 E), suggesting that SubAB and DTT could also 
induce phosphorylation of IRE1 at sites different from S729. 
Nevertheless, in the face of S729A mutation, the enhanced 
expression of XBP1 in response to SubAB or DTT was completely 
blocked (Fig. 6, A, C, and D).
Figure 4. HEL-immunized S729A mice generate significantly less CD138+ plasma cells in the spleens and bone marrow, and those plasma cells express 
less XBP1s. (A) 3-d LPS-stimulated WT and S729A B cells were radiolabeled for 4 h and chased in the absence or presence of 1 nM SubAB for a course of 8 h. 
Lysates were immunoprecipitated for IRE1, which was then analyzed by SDS-PAGE and autoradiography. (B) Human H929 cells were treated with 5 mM DTT 
for 3 h and immunoblotted. (C) Mouse A20 cells were pretreated with 20 µM B-I09 for 12 h, were subsequently exposed to 1.5 nM SubAB for 12 h, and were 
immunoblotted. (D) WT and S729A mice were immunized with HEL plus CFA and boosted three times with HEL plus IFA. Bone marrow cells isolated from 
immunized mice were stained for CD138, B220, and XBP1s. Gated B220+ and CD138+ populations were analyzed for expression of XBP1s. FSC-A, forward scatter 
area. (E) Percentages of CD138+ plasma cells in the bone marrow of HEL-immunized WT and S729A mice. (F) MFI of XBP1s in CD138+ plasma cells in the bone 
marrow of HEL-immunized WT and S729A mice. (G) Percentages of CD138+ plasma cells in spleens of HEL-immunized WT and S729A mice. (H) MFI of XBP1s 
in CD138+ plasma cells in spleens of HEL-immunized WT and S729A mice. (I and J) Serum levels of anti–HEL IgG (I) and IgG1 (J) in immunized WT and S729A 
mice were determined by ELI SA. Data are shown as means ± SEM.
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Phosphorylation at S729 of IRE1 was responsible for RIDD
XBP1 deficiency leads to the up-regulated levels of IRE1 and RIDD 
in liver, pancreas, and B cells (Lee et al., 2011; Hur et al., 2012; So 
et al., 2012; Benhamron et al., 2014). In XBP1-deficient B cells, 
μS mRNA is destroyed by RIDD, which leads to significantly 
decreased levels of sIgM (Benhamron et al., 2014). To test the 
potential contribution of S729 phosphorylation of IRE1 to RIDD, 
we crossed S729A mice with B cell–specific XBP1KO (CD19Cre/
XBP1f/f) mice to generate S729A/XBP1KO mice. As critical con-
trols, we generated B cell–specific IRE1KO mice by crossing IRE1f/f 
mice (Zhang et al., 2011) with CD19Cre mice. CD19Cre/IRE1f/f 
mice were further crossed with XBP1f/f mice to generate B cell– 
specific IRE1KO/XBP1KO (CD19Cre/IRE1f/f/XBP1f/f) mice. We puri-
fied B cells from spleens of WT, XBP1KO, IRE1KO, IRE1KO/XBP1KO, 
S729A, and S729A/XBP1KO mice and stimulated those B cells with 
LPS for 3 d (Fig. 7, A and B). Upon LPS stimulation, IRE1KO and 
Figure 5. S729A B cells respond to LPS or CpG-1826 stimulation by producing XBP1s. (A) Naive WT and S729A B cells were stimulated with LPS (20 µg/
ml) for a course of 3 d and immunoblotted. (B) Naive WT B cells were stimulated with LPS or CpG-1826 (0.5 µM) for a course of 3 d, stained for XBP1s and B220, 
and analyzed for gated B220+/XBP1s+ populations. (C) B cells purified from WT and S729A mice were stimulated with LPS for 1 d and continued to be stimulated 
with LPS for an additional 3, 6, 12, and 24 h (the end of day 2). At each time point, B cells were stained for XBP1s and B220 and were analyzed for gated B220+/
XBP1s+ populations. Flow cytofluorometric data are representative of three independent experiments. (D) Naive B cells purified from WT (n = 3) and S729A 
(n = 3) mice were stimulated with LPS for 1 d and continued to be stimulated with LPS for an additional 3, 12, and 24 h. At each time point, B cells were stained 
with XBP1s–Alexa Fluor 647 and B220–Alexa Fluor 488. The gated B220+ populations were analyzed for expression of XBP1s shown as MFI (means ± SD). The 
MFI data are representative of three independent experiments.
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Figure 6. LPS-stimulated S729A B cells fail to respond to secondary ER stress by producing additional XBP1s. (A) 2-d LPS-stimulated WT and S729A B cells 
were exposed to 20 µM B-I09 or 5 mM DTT for 3 h, stained for XBP1s and B220, and gated for B220+/XBP1s+ populations. (B) 2-d LPS-stimulated WT and S729A B 
cells were exposed to 2.5 µM Tg for the indicated times, stained for XBP1s and B220, and gated for B220+/XBP1s+ populations. (C) 2-d LPS-stimulated WT and S729A 
B cells were exposed to 1.5 nM SubAB for the indicated times, stained for XBP1s and B220, and gated for B220+/XBP1s+ populations. (D) 2-d LPS-stimulated WT 
and S729A B cells were exposed to 1 nM SubAB, 5 µg/ml Tu, or 2.5 µM Tg for 12 h or were exposed to 5 mM DTT for 3 h and immunoblotted. (E) 2-d LPS-stimulated 
WT and S729A B cells were exposed to 1 nM SubAB or 2.5 µM Tg for 12 h or were exposed to 5 mM DTT for 3 h, lysed, and immunoprecipitated for IRE1. Bead-bound 
IRE1 was treated with CIP for 3 h and immunoblotted for IRE1. Data in this figure are representative of three independent experiments.
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/217/5/1739/441206/jcb_201709137.pdf by U
niversity South Florida H
sl user on 26 February 2020
Tang et al. 
Phosphorylation at S729 of IRE1 regulates RIDD
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709137
1748
IRE1KO/XBP1KO B cells produced a 115-kD ΔIRE1 protein, which 
lacked 100 amino acids (from aa 652 to aa 751) in the kinase 
domain (Fig. 7 A). Consistent with previous studies, the lack of 
XBP1s caused normal and leukemic B cells to produce up-regu-
lated levels of IRE1 (Fig. 7 A; Hu et al., 2009a; Tang et al., 2014), 
contributing to the increased RIDD (Benhamron et al., 2014) 
and decreased protein levels of the μS chains (Fig.  7  A). The 
lack of functional IRE1 in IRE1KO and IRE1KO/XBP1KO B cells abol-
ished RIDD, allowing B cells to continue synthesizing μS chains 
(Fig. 7 A). LPS-stimulated S729A B cells produced XBP1s and syn-
thesized μS chains, and LPS-stimulated S729A/XBP1KO B cells also 
up-regulated the S729-mutated IRE1 protein (Fig. 7 B). Notably, 
the S729A mutation, similar to IRE1KO, abolished RIDD, resulting 
in increased expression of μS mRNA and μS chains in S729A/
XBP1KO B cells (Fig. 7, A–D). In addition, the S729A mutation and 
IRE1KO almost completely blocked RIDD of Tapbp1 and Hgsnat 
mRNAs in XBP1KO B cells (Fig. 7, E and F). Although both S729A 
and IRE1KO abolished RIDD to allow for the recovery of μS chains, 
we did not observe a complete recovery of μS mRNA levels, sug-
gesting that RIDD was not the only mechanism that caused the 
degradation of μS mRNA in XBP1-deficient B cells (Fig. 7 C).
To further confirm that S729 phosphorylation played a role in 
regulating RIDD, we transfected IRE1−/− mouse embryonic fibro-
blasts (MEFs) with IRE1 carrying phosphomimetic mutations 
(S729D and S729E) and showed that these cells expressed signifi-
cantly less mRNA levels of RIDD substrates when compared with 
those transfected with WT IRE1 (Fig. 7, G–M).
SubAB induced RIDD in B cells
Because SubAB triggered S729 phosphorylation effectively 
(Fig. 2, A, D, and E), we tested whether SubAB could induce RIDD 
in B cells. We exposed LPS-stimulated WT and S729A B cells to 
SubAB for 24 h and confirmed that SubAB induced these B cells 
to express high levels of Hspa5 (BiP) and Pdia4 (protein disul-
fide isomerase A4) mRNAs (Fig. 8, A and B). Congruent with our 
flow cytofluorometry data (Figs. 6 C and S5 B), SubAB induced 
LPS-stimulated S729A B cells to express less XBP1s mRNA than 
LPS-stimulated WT B cells (Fig.  8  C). SubAB indeed induced 
RIDD as shown by the decreased levels of μS mRNA in WT but 
not S729A B cells upon SubAB treatment (Fig. 8 D). Because Tu 
did not cause phosphorylation of S729 (Figs. 2 A and S1, C and D), 
we also found that it did not induce RIDD of μS mRNA in B cells 
(Fig. 8 E). We further investigated the response of other RIDD 
substrates in SubAB-treated WT and S729A B cells (Fig. 8, F–J). 
Similar to μS mRNA results (Fig. 8 D), SubAB induced RIDD of 
these mRNA substrates in WT B cells but less so in S729A B cells 
(Fig. 8, F–J).
B-I09 and KIRA6 inhibited RIDD in XBP1-deficient B cells
B-I09 inhibits IRE1 from splicing the XBP1 mRNA (Figs. 2 A, 4 C, 
and 6 A; Tang et al., 2014). We tested whether B-I09 could also 
inhibit RIDD. B-I09 efficiently blocked the degradation of μS 
mRNA in XBP1-deficient B cells (Fig. 8 K), suggesting that B-I09 
was also an inhibitor of RIDD. KIRA6 has a better activity in inhib-
iting IRE1 from cleaving insulin mRNA (an RIDD substrate) than 
from splicing the XBP1 mRNA (Ghosh et al., 2014). Intrigued by 
our results showing that KIRA6 inhibited S729 phosphorylation 
and had little effect in suppressing the expression of XBP1s (Figs. 
2 F and S2, A–D), we hypothesized that KIRA6 could inhibit the 
degradation of μS mRNA in XBP1-deficient B cells and showed 
that this was indeed the case (Fig. 8 L).
Immunized S729A mice produced increased amounts of IgM 
and IgG2b in the blood
To explore the role of S729 in vivo, we immunized WT, XBP1KO, 
S729A, and S729A/XBP1KO mice with NP-Ficoll to interrogate B 
cell–intrinsic role of S729. B cells respond to such immunization 
by producing NP-specific IgM. We analyzed NP-specific IgM lev-
els in sera at 3, 6, and 9 d after immunization (Fig. 9, A–C) and 
detected significantly increased IgM levels in S729A mice on 
day 6, when compared with WT mice (Fig. 9 B). When we com-
pared immunized S729A/XBP1KO with XBP1KO mice, we detected 
consistently increased levels of IgM and increased frequen-
cies of NP-specific plasma cells in S729A/XBP1KO mice (Fig. 9, 
A–D). Although we did not detect a significant difference in NP- 
specific plasma cell frequencies between immunized WT and 
S729A mice (Fig. 9 D), the expression levels of XBP1s were sig-
nificantly lower in plasma cells of immunized S729A mice 
(Fig. 9 E). Such data support the hypothesis that S729A mutation 
compromises IRE1’s function in splicing XBP1 mRNA, leading to 
decreased levels of XBP1s, and in cleaving μS mRNA, leading to 
increased levels of IgM.
Although we did not detect significantly increased anti–HEL 
IgG or IgG1 in S729A mice repeatedly immunized with HEL 
(Fig. 4, I and J), such immunization allowed further class-switch 
recombination. As demonstrated, the γ2b mRNA is an RIDD sub-
strate (Benhamron et al., 2014). We examined anti–HEL IgG2b 
levels in repeated immunized WT and S729A mice and found sig-
nificantly increased serum levels of IgG2b in immunized S729A 
mice (Fig. 9 F), supporting the idea that plasma cells of immu-
nized S729A mice acquired defective RIDD.
Discussion
The kinase domain of IRE1 is critical for the RNase activity of 
IRE1 as demonstrated by our data showing that missing aa 652–
751 in the kinase domain completely blocks the expression of 
XBP1s in LPS-stimulated B cells (Fig. 7 A); however, IRE1 carry-
ing the S729A mutation can still express XBP1s (Figs. 5 A and 7 B). 
In XBP1KO B cells, up-regulated IRE1 undergoes phosphorylation 
at S729 (Fig. 1, F and H) and contributes to RIDD (Fig. 10). This 
is supported by the results showing that the S729A mutation 
can inhibit IRE1 from cleaving RIDD substrates in XBP1KO B cells 
(Fig. 7, B–F). In contrast with inhibiting RIDD in XBP1KO B cells 
by deleting the RNase activity of IRE1 (Benhamron et al., 2014), 
our data showed that deleting the kinase function or mutating 
S729 in the kinase domain of IRE1 was sufficient to block RIDD in 
XBP1KO B cells (Fig. 7, A–F). Distinct from the two different B cell–
specific IRE1KO mouse models in which both XBP1 splicing and 
RIDD are blocked (Fig. 7, A, C, E, and F; Benhamron et al., 2014), 
the S729A mutation only blocks RIDD (Fig. 7, B–F), highlighting 
the critical function of S729 in regulating RIDD in B cells. When 
we immunized WT and S729A mice with a T-independent anti-
gen (NP-Ficoll), we detected increased levels of anti–NP IgM in 
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S729A mice (Fig. 9, A–C). In mice repeatedly immunized with 
a T-dependent antigen (HEL), we also detected significantly 
increased IgG2b levels in S729A mice (Fig. 9 F). Such data sug-
gest that S729 phosphorylation on IRE1 is critical for plasma cells 
to curtail the production of IgM and certain Ig isotypes such as 
IgG2b in response to immunization.
By transfecting insect cells with the cytoplasmic domain (aa 
547–977) of human IRE1, IRE1 was shown to be phosphorylated 
at S551, S562, S724, S726, S729, and T973 (Prischi et al., 2014). 
Although S724, S726, and S729 are located in the activation loop of 
human IRE1 and are hypothesized to be critical for regulating the 
RNase activity of IRE1, IRE1 carrying S724A/S726A/S729A triple 
Figure 7. Phosphorylation at S729 of IRE1 is critical for RIDD. (A) WT, XBP1KO, IRE1KO, and IRE1KO/XBP1KO (double KO; DKO) naive B cells were stimulated 
with 20 µg/ml LPS for a course of 3 d and immunoblotted. (B) WT, XBP1KO, S729A, and S729A/XBP1KO naive B cells were stimulated with LPS for a course 
of 3 d and immunoblotted. Immunoblot data shown in this figure are representative of three independent experiments. (C) Naive B cells from WT, XBP1KO, 
DKO, and S729A/XBP1KO mice were stimulated with LPS for 3 d and lysed for purification of total RNA and synthesis of cDNA. The levels of μS mRNA were 
measured by quantitative RT-PCR, which was performed in triplicate for each sample. Data were normalized to UBC (a house-keeping gene) and are shown 
as means ± SD. (D) 2-d LPS-stimulated XBP1KO and S729A/XBP1KO B cells were further stimulated with LPS for an additional 8, 16, and 24 h. The levels of μS 
mRNA were measured by quantitative RT-PCR. (E and F) WT, XBP1KO, DKO, and S729A/XBP1KO B cells were stimulated with LPS for 3 d. The mRNA levels of 
Tapbp1 (E) and Hgsnat (F) were measured by quantitative RT-PCR. (G–M) IRE1−/− MEFs were transfected with pcDNA3.1 plasmids carrying full-length mouse 
IRE1 cDNA (WT) or carrying the S729D or S729E mutation. The mRNA levels of Ergic3 (G), Scara3 (H), pdgfrb (I), Col6a1 (J), Tapbp1 (K), Bloc1S1 (L), and Hgsnat 
(M) were measured by quantitative RT-PCR 48 h after transfection. Data are shown as means ± SD. All quantitative RT-PCR data shown are representative of 
three independent experiments.
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/217/5/1739/441206/jcb_201709137.pdf by U
niversity South Florida H
sl user on 26 February 2020
Tang et al. 
Phosphorylation at S729 of IRE1 regulates RIDD
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709137
1750
mutations can still robustly splice the XBP1 mRNA (Prischi et al., 
2014), suggesting that phosphorylation of mammalian IRE1 at the 
activation loop is not required for splicing of the XBP1 mRNA. 
Yeast Ire1 carrying all 5 phosphorylation mutations in the acti-
vation loop can still splice HAC1 mRNA (Armstrong et al., 2017). 
When HT1080 cells were transfected with the S724A/S726A dou-
ble mutant or the S724A/S726A/S729A triple mutant, the two 
mutants showed similar effects in splicing XBP1 mRNA, leading 
to the conclusion that the RNase activity of human IRE1 can only 
be enhanced by phosphorylation of S724 and S726 (Prischi et al., 
2014). IRE1 in LPS-stimulated B cells does not require phosphor-
ylation to activate XBP1 (Fig. 1, H and J). When compared with 
LPS-stimulated WT B cells, LPS-stimulated S729A B cells do not 
exhibit changes in the mRNA levels of XBP1s and RIDD substrates 
(Fig. 8, C–J), further suggesting that IRE1 does not require phos-
phorylation at S729 to splice or cleave mRNAs in LPS-stimulated 
WT B cells. Although Tg induces phosphorylation of IRE1 only 
at S729 in LPS-stimulated B cells, SubAB and DTT can induce 
phosphorylation at S729 and other sites in these cells (Fig. 6 E). 
However, S729A mutation completely blocks IRE1’s ability to 
further up-regulate XBP1s to respond to any of these ER stress 
conditions (Fig. 6). We propose that S729 may be the first resi-
due undergoing phosphorylation in the activation loop of IRE1 
in LPS-stimulated WT B cells in response to SubAB treatment as 
indicated by no IRE1 band shift in LPS-stimulated S729A B cells at 
the early time points of the pulse-chase experiment (Fig. 4 A). In 
addition, the slightly decreased levels of XBP1s in LPS-stimulated 
S729A B cells (Fig. 5, A, C, and D; and Figs. 6 D and 7 B) suggest that 
XBP1s may be directly or indirectly stabilized by IRE1 and that the 
replacement of the polar S729 residue by a hydrophobic alanine 
may compromise such a stabilizing effect.
Phosphorylation at S729 of IRE1 occurs in B cells lacking 
XBP1s or exposed to SubAB (Fig. 1, F, H, and I). Both XBP1 defi-
ciency and SubAB treatment lead to degradation of RIDD sub-
strates in B cells, and such degradation can be blocked by S729A 
mutation (Fig. 7, B–F; and Fig. 8, D and F–J). Tu does not induce 
phosphorylation of S729 on IRE1, although it can induce the 
expression of XBP1s by activating other phosphorylation sites 
(Fig. S1, C, D, and J). As expected, Tu fails to induce RIDD of μS 
mRNA in B cells (Fig. 8 E). Together with data showing that RIDD 
Figure 8. SubAB induces RIDD in B cells. (A–D) 2-d LPS-stimulated WT and S729A B cells were exposed to 1 nM SubAB for 24 h. The mRNA levels of Hspa5 
(A), Pdia4 (B), XBP1s (C), and μS (D) were measured by quantitative RT-PCR. (E) 2-d LPS-stimulated WT and S729A B cells were exposed to 5 µg/ml Tu for 24 h. 
The μS mRNA levels were measured by quantitative RT-PCR. (F–J) 2-d LPS-stimulated WT and S729A B cells were exposed to 1 nM SubAB for 24 h. The mRNA 
levels of the indicated genes were measured by quantitative RT-PCR. (K and L) Naive B cells from WT and XBP1KO mice were stimulated with LPS for 3 d. Some 
XBP1KO B cells were incubated with 20 µM B-I09 (K) or 5 µM KIRA6 (L) in the last 24 h of LPS stimulation. The μS mRNA levels were measured by quantitative 
RT-PCR. Data are shown as means ± SD. Quantitative RT-PCR data are representative of three independent experiments.
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is readily observed in IRE1−/− MEFs transfected with phosphomi-
metic mutants of IRE1 (Fig. 7, G–M), phosphorylation at S729 is 
indispensable for RIDD.
In addition to regulating RIDD, phosphorylation at S729 can 
enhance the RNase activity of IRE1 in splicing XBP1 (Fig.  10). 
Although XBP1 splicing can occur in LPS-stimulated S729A B cells 
(Fig. 5, A and C; and Figs. 6 D and 7 B), these B cells fail misera-
bly in their response to secondary ER stress insults (Fig. 6, A–D; 
and Fig. S5). We propose that S729 phosphorylation triggers 
enhanced XBP1 splicing and RIDD, which can together relieve 
ER stress in B cells by synthesizing more lipids and chaperones 
to increase the folding capacity of the ER via enhanced XBP1 
splicing and by reducing the production of μS chains and other 
proteins via RIDD. In B cells that lack XBP1s, S729 phosphoryla-
tion allows activation of RIDD to reduce the amounts of newly 
synthesized unfolded μS chains to enter the ER, thus protecting 
XBP1-deficient B cells from proteotoxicity (Fig. 10). We showed 
previously that SubAB can cleave BiP in B cells, and the resul-
tant C-terminal substrate-binding domain of BiP can efficiently 
sequester the κ light chain together with μ heavy chains inside 
B cells (Hu et al., 2009b); here, SubAB-induced S729 phosphory-
lation can activate RIDD to reduce the production of secretory μ 
chains (Fig. 8 D), representing another tactic of Shiga-toxigenic 
E. coli in dismantling the host’s B cell function.
The IRE1 RNase inhibitor B-I09 inhibits IRE1 from splicing 
XBP1 and engaging RIDD (Figs. 2 A, 4 C, 6 A, and 8 K; Tang et al., 
2014), supporting that the “same” RNase domain of IRE1 splices 
XBP1 mRNA and cleaves μS mRNA. We hypothesize that phos-
phorylation at S729 might allow dimeric or oligomeric IRE1 to 
interact with other proteins in the UPRosome (Hetz et al., 2011; 
Figure 10. A model depicting S729 phosphorylation of IRE1 enhancing the expression of XBP1s and activating RIDD in B cells.
Figure 9. Immunized S729A mice produce 
increased serum levels of IgM and IgG2b. 
(A–C) Serum levels of anti–NP IgM in WT, 
XBP1KO, S729A, and S729A/XBP1KO mice (n = 5 
per group) were determined by ELI SA on day 3 
(A), day 6 (B), and day 9 (C) after immunization 
with NP-Ficoll on day 0. (D and E) On day 9, 
NP-Ficoll–immunized mice were sacrificed to 
analyze for anti–NP IgM–secreting plasma cells in 
the bone marrow by ELI SPOT (D). Bone marrow 
cells isolated from immunized mice were stained 
with CD138-PE, B220-BV605, and XBP1s–Alexa 
Fluor 647. Gated CD138+ populations were ana-
lyzed for the expression of XBP1s (E). (F) Serum 
levels of anti–HEL IgG2b in WT and S729A mice 
immunized with HEL/CFA followed by 3 boosts 
with HEL/IFA were determined by ELI SA. Data 
are shown as means ± SEM.
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Woehlbier and Hetz, 2011), resulting in further assembly of its 
RNase domains to assume a more “relaxed and promiscuous” con-
formation to enhance XBP1 splicing and cleave RIDD substrates. 
Because S729 phosphorylation of IRE1 is critical in regulating 
RIDD, small molecules that specifically inhibit S729 phosphor-
ylation can be useful tools in interrogating the biology of RIDD 
in human diseases. KIRA6 is one such inhibitor because it rap-
idly inhibits S729 phosphorylation of IRE1 and suppresses RIDD 
without affecting the levels of XBP1s (Figs. 2 F, 8 L, and S2, A–D).
Materials and methods
Generation and maintenance of the S729A 
knock-in mouse model
10 µg of the targeting vectors were transfected by electropora-
tion of C57BL/6 (B6) embryonic stem (ES) cells. After selection 
with the G418 antibiotic, surviving clones were expanded for PCR 
analysis to identify recombinant ES clones. Primers designed 
within the Neo cassette (forward) and downstream of the short 
homology arm (reverse) were used for screening by PCR to iden-
tify positive clones, which were then selected for expansion and 
reconfirmed for short homology arm integration. Sequencing 
was performed on purified PCR DNA to confirm the presence of 
the point mutation. Secondary confirmation of positive clones 
identified by PCR was performed using Southern blotting analy-
sis to confirm the integration of 3′ and 5′ homology arms. In brief, 
restriction-digested DNA was electrophoretically separated on a 
0.8% agarose gel, transferred to a nylon membrane, and hybrid-
ized with a probe targeted against the Neo cassette. The probe 
includes part of the Neo sequence as well as the mouse genomic 
sequence and hybridizes to the Neo cassette and the genomic 
sequence to generate two bands (targeted and WT) on the blot. 
DNA from the B6 mouse strain was used as the WT control. Each 
clonal cell culture was sampled before injection and had an equal 
passage number to the injected cells. For each clone, 20 meta-
phase spreads were analyzed, and the percent euploidy in each 
culture was calculated following the Cold Spring Harbor Labo-
ratory’s chromosome counting protocol of ignoring metaphase 
spreads with <39 chromosomes. All clones passed the required 
70% euploid cutoff. Targeted ES cells were microinjected into 
BALB/c blastocysts. Resulting chimeras with a high percentage 
black-coat coloring were mated to C57BL/6 flippase (FLP) mice 
to remove the Neo cassette, which is flanked by FLP recognition 
target sites. Tail DNA samples from pups with black coat color-
ing were screened for the deletion of the Neo cassette by PCR 
using designed primers. Again, sequencing was performed on 
purified PCR DNA to confirm the presence of the desired point 
mutation. We also confirmed the absence of the FLP transgene 
and reconfirmed the integration of the short homology arm by 
PCR using specific primers. The mice, confirmed for somatic Neo 
deletion, were mated to WT B6 mice to generate germline Neo- 
deleted mice, which were again genotyped for the presence of Neo 
deletion and the absence of the FLP transgene. These germline 
Neo-deleted mice were mated to each other to generate homozy-
gous mice. Homozygous male S729A mice must be crossed with 
heterozygous female S729A mice to maintain the S729A mouse 
colony. We set up >12 breeding pairs using homozygous S729A 
female mice, but these homozygous S729A female mice never 
gave birth to pups, consistent with a previous study showing a 
critical role for IRE1 in the placenta during pregnancy (Iwawaki 
et al., 2009). Histological examinations of the female reproduc-
tive organs in S729A mice showed the normal ovarian cycle with 
follicles of every stage identified. The S729A male and female 
pups are born at a normal Mendelian ratio. In the S729A mouse 
colony, ∼50% pups carry homozygous S729A alleles.
Mice
The S729A knock-in mice, together with XBP1f/f, CD19Cre/
XBP1f/f, IRE1f/f (provided by D. Fang, Northwestern Univer-
sity, Chicago, IL), CD19Cre/IRE1f/f, IRE1f/f/XBP1f/f, CD19Cre/
IRE1f/f/XBP1f/f, S729A/XBP1f/f, and S729A/CD19Cre/XBP1f/f 
mice were maintained at our animal facility strictly following 
the guidelines provided by the Wistar Institute Committee 
on Animal Care.
Study approval
All experiments involving the use of mice were performed fol-
lowing protocols approved by the Institutional Animal Care and 
Use Committee at the Wistar Institute.
Purification of mouse B cells
Splenocytes were obtained from mice by mashing the spleens 
through cell strainers followed by RBC lysis (Sigma-Aldrich). 
Mouse B cells were purified from mouse spleens by negative 
selection using CD43 (Ly48) or pan-B magnetic beads (Miltenyi 
Biotec), according to the manufacturer’s instructions.
Mass spectrometry
Protein bands were stained with Coomassie brilliant blue G-250, 
excised, reduced, and alkylated. In-gel proteolytic digestion with 
trypsin, chymotrypsin, or both was used to prepare samples for 
peptide sequencing with reverse-phase LC-MS/MS using Dionex 
ultraperformance liquid chromatography (Thermo Fisher Sci-
entific) interfaced with an electrospray hybrid, linear-ion trap–
orbital ion trap (LTQ Orbitrap; Thermo Fisher Scientific) mass 
spectrometer. Protonated peptide molecules were measured in 
positive ion mode in the survey scan (MS1), before selection of 
the top seven ion signals for tandem mass spectrometry. Frag-
ment ion mass spectra obtained from LC-MS/MS were submit-
ted to SEQ UEST (Thermo Fisher Scientific) and MAS COT soft-
ware (Matrix Science) searches for entries of the appropriate 
species in the UniProt database. In addition to mass tolerances 
appropriate to the instrument, two missed cleavages and vari-
able modifications (Ser/Thr/Tyr phosphorylation and Met 
oxidation) were included in the search parameters. Matched 
sequences were summarized in Scaffold software (Proteome 
Software); single peptide matches for protein identifications 
and all phosphorylated peptides were further verified by manual 
inspection of the tandem mass spectrometry spectra and rela-
tively quantified using XICs.
Flow cytometric analysis
Single-cell suspensions from spleens, bone marrow, or periph-
eral lymph nodes were blocked for 30 min using FBS. Cell-surface 
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staining was achieved by incubating cells at 4°C for 30 min with 
fluorescence-conjugated anti–mouse antibodies (clone; source): 
XBP1s–Alexa Fluor 647 (Q3-695; BD), XBP1s-phycoerythrin (PE; 
Q3-695; BD), B220–Alexa Fluor 488 (RA3-6B2; BioLegend), 
B220-BV605 (RA3-6B2; BioLegend), CD43-PE (eBioR2/60; 
eBioscience), CD19–Alexa Fluor 647 (6D5; BioLegend), IgM-
PE-Cy7 (RMM-1; BioLegend), IgD-FITC (11-26c.2a; BioLegend), 
GL7-PE (GL7; BioLegend), AA4.1-PE-Cy7 (AA4.1; BioLegend), 
CD1d-PerCP-Cy5.5 (1B1; BioLegend), CD23-FITC (B3B4; BioLeg-
end), CD3-APC-Cy7 (145-2C11; BioLegend), CD4-BV605 (RM4-5; 
BioLegend), CD8α-PE-Cy7 (53–6.7; BioLegend), and CD138-PE 
(281–2; BioLegend). Viability staining was accomplished using 
DAPI exclusion during acquisition. Acquisition of B, T, and den-
dritic cell populations was performed on an LSR II cytometer 
(BD) harboring a custom configuration for the Wistar Institute. 
Cytometry data were analyzed using FlowJo software (7.6.1; 
Tree Star Inc.).
Antibodies and reagents
Rabbit polyclonal antibodies against recombinant mouse IRE1 
(aa 21–445) and a phospho-S729 peptide were generated and 
affinity purified. Polyclonal antibodies against BiP/GRP78 and 
PDI were also generated in rabbits. The following antibodies 
were obtained commercially: IRE1 (Cell Signaling Technology), 
XBP1s (Cell Signaling Technology), GRP94 (Stressgen), p97 
(Fitzgerald Industries), μ (SouthernBiotech), κ (SouthernBio-
tech), phospho-ERK1/2 (Cell Signaling Technology), ERK1/2 
(Cell Signaling Technology), phospho–nuclear factor κ–light 
chain enhancer of activated B cells (NF-κB) p105 (Cell Signaling 
Technology), phospho–NF-κB p65 (Cell Signaling Technology), 
and caspase 3 (Cell Signaling Technology). LPS (Sigma-Al-
drich), DTT (Sigma-Aldrich), BFA (Cell Signaling Technology), 
CpG-1826 oligodeoxynucleotides (TIB-Molbiol), Tu (Enzo Life 
Sciences), Tg (Enzo Life Sciences), KIRA6 (EMD Millipore), 
staurosporine (EMD Millipore), imatinib (EMD Millipore), 
sunitinib (Sigma-Aldrich), MG-132 (Enzo Life Sciences), Z-VAD-
FMK (Enzo Life Sciences), chloroquine (Cell Signaling Technol-
ogy), and NH4Cl (Sigma-Aldrich) were also purchased from 
commercial sources. Native and mutant SubAB were purified 
as described previously (Paton et al., 2004; Talbot et al., 2005). 
Shiga toxin 1, Shiga toxin 2, cholera toxin, and pertussis toxin 
were purchased from the List Biological Laboratories. We devel-
oped and chemically synthesized the IRE1 RNase inhibitor B-I09 
(Tang et al., 2014).
Cell culture
Purified naive mouse B cells, mouse 5TGM1 myeloma cells (pro-
vided by L.A. Hazlehurst, West Virginia University, Morgantown, 
WV), mouse A20 B cell lymphoma cells (ATCC), and human H929 
myeloma cells (ATCC) were cultured in the RPMI-1640 medium 
(Gibco) supplemented with 10% heat-inactivated FBS, 2  mM 
l-glutamine, 100 U/ml penicillin G sodium, 100 µg/ml strep-
tomycin sulfate, 1 mM sodium pyruvate, 0.1 mM nonessential 
amino acids, and 0.1  mM β-mercaptoethanol (β-ME). 5TGM1 
cells were tested for the secretion of Ig and the surface expres-
sion of plasma cell marker CD138 every 6 mo. All cell lines were 
negative for mycoplasma contamination.
Site-directed mutagenesis and transfection
IRE1−/− MEFs were provided by D. Ron (University of Cambridge, 
Cambridge, England, UK) and cultured in DMEM supplemented 
with 10% FBS. Full-length mouse IRE1 cDNA was cloned into 
pcDNA3.1+ plasmid between EcoRI and NotI restriction sites. 
Mutagenesis was performed according to the manufacturer's 
instructions using the QuikChange II XL site-directed mutagen-
esis kit (Agilent Technologies). The sense oligonucleotides used 
for S729D and S729E were as follows, with the altered codons 
underlined: 5′-GGC ACA GTT TCA GCC GCC GTGATGGG GTA CCT 
GGC-3′ (S729D) and 5′-GGC ACA GTT TCA GCC GCC GTGAGGGG GTA 
CCT GGC-3′ (S729E). IRE1−/− MEFs were transfected using Lipo-
fectamine 3000 reagent (Thermo Fisher Scientific) according to 
the manufacturer’s instructions.
Protein isolation, immunoprecipitation, dephosphorylation, 
and immunoblotting
Cells were lysed in radioimmunoprecipitation assay buffer 
(10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS, and 1  mM EDTA) supplemented with 
protease inhibitors (Roche) and phosphatase inhibitors. Protein 
concentrations were determined by bicinchoninic acid assays 
(Thermo Fisher Scientific). IRE1 was immunoprecipitated with 
an anti–mouse IRE1 antibody and protein G–Sepharose beads 
(Sigma-Aldrich). Bead-bound IRE1 was dephosphorylated using 
λPPase (New England Biolabs, Inc.) or CIP (New England Biolabs, 
Inc.). Proteins were boiled in SDS-PAGE sample buffer (62.5 mM 
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and 0.1% bromophenol 
blue) with β-ME, analyzed by SDS-PAGE, and transferred to 
nitrocellulose membranes, which were then blocked in 5% non-
fat milk (wt/vol in PBS) and immunoblotted with the indicated 
primary antibodies and appropriate HRP-conjugated secondary 
antibodies. Immunoblots were developed with Western Light-
ning chemiluminescence reagent (Perkin-Elmer).
Pulse-chase experiments, immunoprecipitation, and protein 
dephosphorylation
Cells were starved in methionine- and cysteine-free media con-
taining dialyzed FBS for 1 h and pulse-labeled with 250 µCi/ml 
[35S]methionine and [35S]cysteine (Perkin-Elmer) for the indi-
cated times. After labeling, cells were incubated in the chase 
medium containing unlabeled methionine (2.5 mM) and cyste-
ine (0.5 mM). At the end of each chase interval, cells were lysed 
in radioimmunoprecipitation assay buffer containing protease 
inhibitors. Precleared lysates were incubated with an anti–mouse 
IRE1 antibody and protein G–Sepharose beads. To enzymatically 
remove the phosphate group, bead-bound IRE1 was incubated 
with λPPase. Samples were boiled in SDS-PAGE sample buffer 
(62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and 0.1% bro-
mophenol blue) with β-ME, analyzed by SDS-PAGE, and visual-
ized by autoradiography.
RT-PCR
Total RNA was isolated with TRIzol reagent (Invitrogen). cDNA 
was synthesized from RNA with Superscript II reverse tran-
scription (Invitrogen). The following sets of primers were used 
together with Platinum Taq DNA polymerase (Invitrogen) in PCR 
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to detect the expression of mouse μS, 5′-CAC ACT GTA CAA TGT 
CTC CCT-3′ and 5′-AAA ATG CAA CAT CTC ACT CTG-3′; mouse UBC, 
5′-CAG CCG TAT ATC TTC CCA GACT-3′ and 5′-CTC AGA GGG ATG CCA 
GTA ATC TA-3′; mouse XBP1s, 5′-GTC CAT GGG AAG ATG TTC TGG-3′ 
and 5′-CTG AGT CCG AAT CAG GTG CAG-3′; mouse Hspa5, 5′-TGT 
CTT CTC AGC ATC AAG CAA GG-3′ and 5′-CCA ACA CTT TCT GGA 
CAG GCTT-3′; mouse Pdia4, 5′-GGG CTC TTT CAG GGA GAT GG-3′ 
and 5′-GGG AGA CTT TCA GGA ACT TGGC-3′; mouse Itgb2, 5′-CTT 
TCC GAG AGC AAC ATC CAGC-3′ and 5′-GTT GCT GGA GTC GTC AGA 
CAGT-3′; mouse Ergic3, 5′-GTT CAA GAA ACG ACT AGA CAA GGA-
3′ and 5′-ACC TCG ACT TTC CCA AGC TC-3′; mouse Bloc1S1, 5′-GAG 
GAG AGA AGC TAT CGC TGCA-3′ and 5′-CTG GAC CTG TAG AGT CTT 
CACC-3′; mouse Tapbp1, 5′-ACC ATT CCC AGG AAC TCA AA-3′ and 
5′-GAG AAG AAG GCT GTT GTT CTGG-3′; mouse Hgsnat, 5′-TCT CCG 
CTT TCT CCA TTT TG-3′ and 5′-CGC ATA CAC GTG GAA AGT CA-3′; 
mouse Scara3, 5′-TGC ATG GAT ACT GAC CCT GA-3′ and 5′-GCC GTG 
TTA CCA GCT TCT TC-3′; mouse Col6a1, 5′-TGC TCA ACA TGA AGC 
AGA CC-3′ and 5′-TTG AGG GAG AAA GCT CTG GA-3′; and mouse 
Pdgfrb, 5′-AAC CCC CTT ACA GCT GTC CT-3′ and 5′-TAA TCC CGT 
CAG CAT CTT CC-3′.
Immunization
Mice were intraperitoneally immunized with HEL (100 µg/
mouse; Sigma-Aldrich) mixed in CFA or IFA (Sigma-Aldrich) or 
with NP55-aminoethylcarboxymethyl-Ficoll (40 µg/mouse; LGC 
Biosearch Technologies) in PBS.
ELI SA and enzyme-linked immunospot (ELI SPOT) assay
For ELI SA, plates were coated with HEL or NP23-BSA. ELI SA 
analyses of mouse IgM, IgG, IgG1, and IgG2b in immunized mouse 
sera were achieved with HRP-conjugated secondary antibodies 
against each mouse antibody isotype (SouthernBiotech) and 
3,3′,5,5′-tetramethylbenzidine liquid substrate system (Sig-
ma-Aldrich). For ELI SPOT assay, MultiScreen-IP filter plates 
(EMD Millipore) were coated with NP23-BSA. Bone marrow cells 
were serially diluted across the plate and then incubated for 16 h 
at 37°C. HRP-conjugated goat anti–mouse IgM antibodies (South-
ernBiotech) diluted in blocking buffer (10% FBS in PBS) were 
added. Spots were detected with the 3,3′,5,5′-tetramethylbenzi-
dine substrate for ELI SPOT (Mabtech) and scanned and counted 
with an ImmunoSpot Analyzer (Cellular Technology Ltd.).
Statistics
For comparison of percentages of cell populations among exper-
imental groups, data were graphed as means ± SEM. Statistical 
significance (P < 0.05) was determined by Student’s t test.
Online supplemental material
Fig. S1 shows that Tg, but not Tu, BFA, or MG132, induces IRE1 to 
undergo phosphorylation at S729. Fig. S2 shows that KIRA6 rapidly 
suppresses SubAB-induced S729 phosphorylation of IRE1 and that 
Shiga toxins, cholera toxin, and pertussis toxin do not induce S729 
phosphorylation even when used at high concentrations. Fig. S3 
documents the generation of the S729A mouse model and shows 
that B cells develop normally in the bone marrow of unimmunized 
S729A mice and that after immunization, the percentages of pro– 
and mature B cells increase in the bone marrow of S729A mice. 
Fig. S4 documents normal B and T cell percentages in the spleens 
and lymph nodes of unimmunized S729A mice and shows that 
after immunization, the percentages of CD19+ B cells decrease 
in the lymph nodes, whereas the percentages of CD4+ and CD8+ 
T cells increase in the spleens and lymph nodes of S729A mice. 
Fig. S5 shows that LPS-stimulated B cells from S729A mice fail to 
respond to Tg or SubAB by enhancing the expression of XBP1s.
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